# Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

> **NCT01812525** · PHASE3 · COMPLETED · sponsor: **Raphaelle Jaquet-Pilloud** · enrollment: 120 (actual)

## Conditions studied

- Moderate to Severe Bronchiolitis

## Interventions

- **DRUG:** NaCl 3%
- **OTHER:** Standard therapy

## Key facts

- **NCT ID:** NCT01812525
- **Lead sponsor:** Raphaelle Jaquet-Pilloud
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01812525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01812525, "Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01812525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*